HHH:PA:PA-HSBC S&P 500 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 49.104

Change

+0.37 (+0.76)%

Market Cap

USD 7.22B

Volume

502.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.26 (+0.58%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.55 (+0.74%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.48 (+0.43%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.17 (+0.52%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.02 (+0.41%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.50 (+0.85%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.59 (+0.50%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.03 (+0.49%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.33 (+0.43%)

USD 5.38B
ECRP:PA Amundi Index Solutions - Amund..

-0.01 (-0.01%)

USD 4.63B

ETFs Containing HHH:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.85% 12% F 18% F
Dividend Return 0.52% 24% F 16% F
Total Return -14.33% 14% F 19% F
Trailing 12 Months  
Capital Gain 2.17% 36% F 54% F
Dividend Return 1.19% 15% F 13% F
Total Return 3.36% 42% F 56% F
Trailing 5 Years  
Capital Gain 83.35% 77% C+ 79% B-
Dividend Return 9.22% 27% F 25% F
Total Return 92.57% 80% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 16.12% 86% B+ 82% B
Dividend Return N/A 61% D- 34% F
Total Return N/A 74% C 88% B+
Risk Return Profile  
Volatility (Standard Deviation) N/A 52% F 90% A-
Risk Adjusted Return N/A 51% F 27% F
Market Capitalization 7.22B 98% N/A 93% A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike